Your title is Business Development Manager.
You will report to Vice President, TIDES Europe and America Business Department
Responsibilities
- Prospecting for TIDES new drug development contacts and companies who would benefit from Jiuzhou Pharma CDMO services.
- Obtains conferences and meetings to present Jiuzhou Pharma services to prospective and existing clients via email, phone, and web-conferencing systems. Travel to local client meetings where possible.
- Participates in tradeshows to raise profile of Jiuzhou Pharma and generate leads
- Prepare and negotiate quotations with clients
- Drives business, discusses CDAs, specifications, requirements and agreements both with customers and internally
- Acts upon, refers and follows up on leads from both sales and marketing campaigns.
- Increase awareness of Jiuzhou Pharma marketing initiatives, including scheduling meetings at tradeshows and promoting registrations for webinars and seminars.
- Maintains knowledge of industry trends, funding, regulatory influence, mergers and acquisitions, in-out licensing of products/technologies, government/private grants and contacts, new drug development and approvals, related patent grants and notifications, market growth of small, med, and large cap companies.
- Develops a social network of industry-related contacts via LinkedIn
- Proposes new ideas to increase performance for Jiuzhou Pharma goals.
- Documents information in Client Relationship Management (CRM), including contacts, pre-screened/qualified leads, and new account information as required.
Qualifications
- Chemical background (MSc or PhD),
- Experience in CDMO business (peptides preferred),
- Minimum 3-5 years’ experience in sales
- Track record of selling to the pharmaceutical industry and biotech companies,
- Experience in working in an international dynamic environment
- Ideally residing in one of the key biotech areas such San Francisco, San Diego or Boston
BD Manager (USA) in United States at Jiuzhou Pharma/九洲药业
This position is listed as full time and onsite. It was posted 3 days ago.